RNF168 and breast carcinoma: Despite no evidence yet existing to show that Aurora-A can compete with FOXM1 ubiquitin ligases, it will be interesting to investigate the potential interplay between nuclear Aurora-A and RNF168 in regulating FOXM1 levels in breast cancer.